| |
No AKI
|
AKI (renal replacement)
|
p-value
|
|---|
|
Baseline
| | | |
|
Male% (n)
|
64(40)
|
75(6)
|
0.79
|
|
Age ys
|
72.6 ± 10.1
|
80 ± 3.7ys
|
0.003
|
|
Weight kg
|
83 ± 15
|
87 ± 14
|
0.51
|
|
Baseline Crea mg/dl
|
1.09 ± 0.3
|
1.6 ± 0.84
|
0.13
|
|
Baseline GFR stage
|
2.2 ± 0,6
|
2.25 ± 0,6
|
0.8
|
|
Elective% (n)
|
100(62)
|
100(8)
| |
|
ASA class ≥II% (n)
|
34(21)
|
62(5)
|
0.13
|
|
Diabetes% (n)
|
29(18)
|
37(3)
|
0.45
|
|
LV function reduced% (n)
|
53(33)
|
37(3)
|
0.47
|
|
Surgical data
| | | |
|
Bypass time min
|
116 ± 39
|
155 ± 38
|
0.01
|
|
Cross-clamp time min
|
72 ± 32
|
102 ± 36
|
0.02
|
|
Urine output on bypass ml
|
360 ± 290
|
315 ± 310
|
0.32
|
|
Post-filtration CPB% (n)
|
8(5)
|
37(3)
| |
|
CABG% (n)
|
62(39)
|
25(2)
|
0.05
|
|
Postoperative data
| | | |
|
Fluid balance 24 h ml
|
1103 ± 1026
|
1403 ± 860
|
0.001
|
|
Furosemide total dose 48 h (mg)
|
90 ± 60
|
98 ± 65
|
0.4
|
|
Secondary outcome
| | | |
|
Length ICU stay d
|
1,58 ± 1.89
|
23.25 ± 20.88
|
0.000
|
|
Length hospital stay d
|
11 ± 5.9
|
30.6 ± 19.1
|
0.000
|
|
Mortality 30d% (n)
|
6.4(4)
|
25(2)
|
0.1
|
- Significant differences were found in CPB times, length of hospital and ICU stay and age.
